Clint Cheng

Richmond, BC (CAN)
Role(s):

Belevo Life Sciences

Location: Richmond
Industry: Bio-Technology
Year Founded: 2007
Number Employees: INVALID
Description: We target a $50 billion times two opportunity in pharmaceutical industry: $50 billion R&D expenses worldwide and $50 billion capex that yields little but bankruptcies in China. We acquire non-performing Chinese assets, upgrade them and provide services to foreign biotechs, so as to reduce R&D costs dramatically. We adopt a unique business model by offering customers partial ownership of related facilities coupled with deep discounted prices for services, thereby we will have cash flows from both sources which can support exponential expansion, meanwhile we will have unbeatable customer loyalty and cost structure. We are on the way to set up the first joint venture with a Chinese pharmaceutical company which will contribute land, building, equipment etc. We are also in talk with a Ch